- Title
- Defining Endpoints and Biomarkers in Inflammatory Bowel Disease: Moving the Needle Through Clinical Trial Design
- Creators
- Maria T Abreu - Division of Gastroenterology, University of Miami Miller School of Medicine, Miami, Florida. Electronic address: mabreu1@med.miami.eduWilliam J Sandborn - Division of Gastroenterology, University of California San Diego, La Jolla, California
- Publication Details
- Gastroenterology (New York, N.Y. 1943), Vol.159(6), pp.2013-2018.e7
- Publisher
- United States
- Academic Unit
- Miller School of Medicine; UMMG Dept of Medicine - Gastroenterology
- Language
- English
- Resource Type
- Journal article
- PMID
- 32961246
- Record Identifier
- 991031578623902976
Journal article
Defining Endpoints and Biomarkers in Inflammatory Bowel Disease: Moving the Needle Through Clinical Trial Design
Gastroenterology (New York, N.Y. 1943), Vol.159(6), pp.2013-2018.e7
2020-12
PMID: 32961246
Metrics
6 Record Views
InCites Highlights
These are selected metrics from InCites Benchmarking & Analytics tool, related to this output
- Collaboration types
- Domestic collaboration
- Citation topics
- 1 Clinical & Life Sciences
- 1.120 Inflammatory Bowel Diseases & Infections
- 1.120.139 Ulcerative Colitis
- Web Of Science research areas
- Gastroenterology & Hepatology
- ESI research areas
- Clinical Medicine
UN Sustainable Development Goals (SDGs)
This output has contributed to the advancement of the following goals:
Source: InCites